Cargando…

Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease

BACKGROUND & OBJECTIVE: The risk of restenosis and other adverse cardiovascular events with bare-metal stents have increased with smaller stent diameters and longer stent lengths. However, the exact impact of stent size on the short-term outcomes of drug-eluting stent (DES) implantations has not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adnan, Yasir, Noor, Lubna, Dar, Muhammad Habeel, Ali, Umair, Hafizullah, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648972/ https://www.ncbi.nlm.nih.gov/pubmed/29067073 http://dx.doi.org/10.12669/pjms.334.13068

Ejemplares similares

Short term clinical outcomes of Everolimus-eluting stents in patients with stable angina pectoris
por: Dar, Muhammad Habeel, et al.
Publicado: (2018)

Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
por: Nayyer-uz-Zaman,, et al.
Publicado: (2018)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
por: Fujita, Hiroshi, et al.
Publicado: (2014)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries
por: Deng, Jie, et al.
Publicado: (2013)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation
por: Singh, Gurpreet, et al.
Publicado: (2019)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs
por: Kim, Hyun Kuk, et al.
Publicado: (2012)

Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm
por: Guttmann, Oliver P., et al.
Publicado: (2016)

Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis
por: Valencia, José, et al.
Publicado: (2007)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes
por: Jing, Juehua
Publicado: (2014)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019)

Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease
por: Gabbasov, Zufar, et al.
Publicado: (2018)

One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2016)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

The Resolute™ Integrity Zotarolimus-Eluting Stent in Coronary Artery Disease: A Review
por: Banerjee, Subhash
Publicado: (2013)

Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries
por: Ruiter, Matthijs S., et al.
Publicado: (2016)

Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2019)

Coronary artery perforation successfully treated with a second drug-eluting stent
por: Strycek, Matej, et al.
Publicado: (2023)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Exclusion of a Giant Coronary Artery Aneurysm With Covered Stents Using a Long Drug-Eluting Stent Scaffold
por: Cotter, Ryan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_la5u7q7ssg844qof9adjs8ck97